| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |